Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Lower vitamin D levels are linked to more severe alopecia areata.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Alopecia areata treatments often don't lead to lasting improvement.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Ayurvedic treatment improved hair condition and density safely in a woman with hair loss.

The treatment with Bakuchiol and Neem oil significantly improved hair growth and was well-received by most participants.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Intralesional steroids improve Alopecia Areata, and trichoscopy effectively tracks this improvement.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Baricitinib is effective and safe for treating severe alopecia areata.

Compound glycyrrhizin combined with conventional treatments effectively and safely promotes hair regrowth in alopecia areata patients.

Compound glycyrrhizin with conventional treatments is effective and safe for promoting hair regrowth in alopecia areata.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Deucravacitinib helped a man regrow hair significantly.

Certain NK cell changes in blood may indicate alopecia areata progression.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Changes in skin bacteria may relate to alopecia areata severity.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Microneedling mildly regrows hair in androgenetic alopecia but not in other types.